Is Ibio Stock a Good Investment?
Ibio Investment Advice | IBIO |
- Examine Ibio's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Ibio's leadership team and their track record. Good management can help Ibio navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Ibio's business and its evolving consumer preferences.
- Compare Ibio's performance and market position to its competitors. Analyze how Ibio is positioned in terms of product offerings, innovation, and market share.
- Check if Ibio pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Ibio's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Ibio Inc stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Ibio Inc is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | OK | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Examine Ibio Stock
Researching Ibio's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 32.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. Ibio Inc recorded a loss per share of 4.03. The entity last dividend was issued on the 11th of June 2018. The firm had 1:20 split on the 29th of November 2023.
To determine if Ibio is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Ibio's research are outlined below:
| Ibio Inc is way too risky over 90 days horizon | |
| Ibio Inc appears to be risky and price may revert if volatility continues | |
| Ibio Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 225 K. Net Loss for the year was (24.91 M) with profit before overhead, payroll, taxes, and interest of 2.17 M. | |
| Ibio Inc currently holds about 33.52 M in cash with (18.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.72, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Latest headline from MacroaxisInsider: Insider Trading |
Ibio uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Ibio Inc. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Ibio's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of February 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact Ibio's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Ibio's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-09-27 | 2021-06-30 | -0.04 | 0.01 | 0.05 | 125 | ||
2023-05-15 | 2023-03-31 | -0.36 | -0.5532 | -0.1932 | 53 | ||
2022-02-14 | 2021-12-31 | -1 | -1.25 | -0.25 | 25 | ||
2021-11-15 | 2021-09-30 | -1.25 | -1.0 | 0.25 | 20 | ||
2021-05-17 | 2021-03-31 | -1.25 | -1.0 | 0.25 | 20 | ||
2024-09-25 | 2024-06-30 | -0.47 | -0.9019 | -0.4319 | 91 | ||
2023-02-14 | 2022-12-31 | -0.62 | -1.08 | -0.46 | 74 | ||
2023-09-27 | 2023-06-30 | -0.41 | 0.26 | 0.67 | 163 |
Ibio's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.3 M.Market Cap |
|
Ibio's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.07) | (1.12) | |
| Return On Capital Employed | (0.67) | (0.70) | |
| Return On Assets | (0.87) | (0.91) | |
| Return On Equity | (1.17) | (1.23) |
Determining Ibio's profitability involves analyzing its financial statements and using various financial metrics to determine if Ibio is a good buy. For example, gross profit margin measures Ibio's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Ibio's profitability and make more informed investment decisions.
Evaluate Ibio's management efficiency
Ibio Inc has return on total asset (ROA) of (0.2973) % which means that it has lost $0.2973 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8415) %, meaning that it created substantial loss on money invested by shareholders. Ibio's management efficiency ratios could be used to measure how well Ibio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 27th of November 2024, Return On Tangible Assets is likely to drop to -1.12. In addition to that, Return On Capital Employed is likely to drop to -0.7. At this time, Ibio's Total Assets are very stable compared to the past year. As of the 27th of November 2024, Non Current Assets Total is likely to grow to about 17.9 M, while Other Current Assets are likely to drop about 711.5 K.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 5.57 | 5.29 | |
| Tangible Book Value Per Share | 4.16 | 3.96 | |
| Enterprise Value Over EBITDA | 0.15 | 0.15 | |
| Price Book Value Ratio | 0.36 | 0.34 | |
| Enterprise Value Multiple | 0.15 | 0.15 | |
| Price Fair Value | 0.36 | 0.34 | |
| Enterprise Value | -1.8 M | -1.9 M |
The operational strategies employed by Ibio management play a crucial role in its market positioning. Assessing these strategies alongside financial data helps us evaluate the stock's investment potential.
Beta (3.37) |
Basic technical analysis of Ibio Stock
As of the 27th of November, Ibio retains the Risk Adjusted Performance of 0.0836, downside deviation of 3.99, and Market Risk Adjusted Performance of 0.9869. Ibio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.Ibio's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Ibio insiders, such as employees or executives, is commonly permitted as long as it does not rely on Ibio's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Ibio insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ibio's Outstanding Corporate Bonds
Ibio issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Ibio Inc uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Ibio bonds can be classified according to their maturity, which is the date when Ibio Inc has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Understand Ibio's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Ibio's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0836 | |||
| Market Risk Adjusted Performance | 0.9869 | |||
| Mean Deviation | 3.76 | |||
| Semi Deviation | 3.54 | |||
| Downside Deviation | 3.99 | |||
| Coefficient Of Variation | 1017.97 | |||
| Standard Deviation | 5.11 | |||
| Variance | 26.09 | |||
| Information Ratio | 0.0727 | |||
| Jensen Alpha | 0.4312 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0931 | |||
| Treynor Ratio | 0.9769 | |||
| Maximum Drawdown | 30.48 | |||
| Value At Risk | (6.47) | |||
| Potential Upside | 7.76 | |||
| Downside Variance | 15.9 | |||
| Semi Variance | 12.54 | |||
| Expected Short fall | (5.09) | |||
| Skewness | 1.17 | |||
| Kurtosis | 3.22 |
| Risk Adjusted Performance | 0.0836 | |||
| Market Risk Adjusted Performance | 0.9869 | |||
| Mean Deviation | 3.76 | |||
| Semi Deviation | 3.54 | |||
| Downside Deviation | 3.99 | |||
| Coefficient Of Variation | 1017.97 | |||
| Standard Deviation | 5.11 | |||
| Variance | 26.09 | |||
| Information Ratio | 0.0727 | |||
| Jensen Alpha | 0.4312 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0931 | |||
| Treynor Ratio | 0.9769 | |||
| Maximum Drawdown | 30.48 | |||
| Value At Risk | (6.47) | |||
| Potential Upside | 7.76 | |||
| Downside Variance | 15.9 | |||
| Semi Variance | 12.54 | |||
| Expected Short fall | (5.09) | |||
| Skewness | 1.17 | |||
| Kurtosis | 3.22 |
Consider Ibio's intraday indicators
Ibio intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ibio stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Ibio Corporate Filings
8K | 25th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
| 10th of October 2024 Other Reports | ViewVerify | |
10K | 24th of September 2024 An amendment to a previously filed Form 10-K | ViewVerify |
Ibio Stock media impact
Far too much social signal, news, headlines, and media speculation about Ibio that are available to investors today. That information is available publicly through Ibio media outlets and privately through word of mouth or via Ibio internal channels. However, regardless of the origin, that massive amount of Ibio data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ibio news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ibio relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ibio's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ibio alpha.
Ibio Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Ibio can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Ibio Corporate Management
| Lisa Middlebrook | Chief Officer | Profile | |
| Stephen Kilmer | Investor Officer | Profile | |
| Marc JD | General Counsel | Profile | |
| Melissa Berquist | VP Health | Profile | |
| Robert Lutz | Chief Officer | Profile | |
| Dr DVM | Chief Officer | Profile |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Ibio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ibio. If investors know Ibio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ibio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (4.03) | Revenue Per Share 0.059 | Quarterly Revenue Growth (0.88) | Return On Assets (0.30) | Return On Equity (0.84) |
The market value of Ibio Inc is measured differently than its book value, which is the value of Ibio that is recorded on the company's balance sheet. Investors also form their own opinion of Ibio's value that differs from its market value or its book value, called intrinsic value, which is Ibio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ibio's market value can be influenced by many factors that don't directly affect Ibio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Ibio's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Ibio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ibio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.